Belvedere Trading
EBS icon

Belvedere Trading’s Emergent Biosolutions EBS Stock Holding History

Belvedere Trading’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,400
Closed -$3.54K – 759
2024
Q1 		$3.54K Sell
1,400
-1,000
-42% -$2.25K ﹤0.01% 636
2023
Q4 		$5.76K Buy
+2,400
New +$5.64K ﹤0.01% 723
2023
Q2 		– Sell
-3,000
Closed -$31.1K – 923
2023
Q1 		$31.1K Buy
+3,000
New +$36.3K ﹤0.01% 655

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Belvedere Trading's EBS Position: Q1 2024 in Review

Belvedere Trading sold out of Emergent Biosolutions (EBS) in Q1 2024, closing a stake of 3,252 shares — an estimated $7.33K sold.

Belvedere Trading first reported a position in EBS in Q4 2023 and held it in 1 quarter. The position peaked at $7.8K in Q4 2023. 122 funds tracked by Wall St. Rank hold EBS as of Q1 2024.

  • Belvedere Trading reported no remaining Emergent Biosolutions position as of Q1 2024 after selling out during the quarter.
  • Belvedere Trading sold 3,252 Emergent Biosolutions shares in Q1 2024, an estimated $7.33K.
  • Belvedere Trading first reported a position in Emergent Biosolutions in Q4 2023 and held it in 1 quarter.
  • Belvedere Trading's Emergent Biosolutions position peaked at $7.8K in Q4 2023.
  • 122 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2024.

Based on Belvedere Trading's 13F filing for Q1 2024, filed 9 May 2024.